

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 7.98229738 |
| 2 | protein maturation by protein folding (GO:0022417) | 6.16300464 |
| 3 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.01768111 |
| 4 | DNA deamination (GO:0045006) | 4.85726628 |
| 5 | sequestering of actin monomers (GO:0042989) | 4.65753332 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.63590047 |
| 7 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.54410622 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 4.51618468 |
| 9 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.46946097 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.41748900 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 4.41748900 |
| 12 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.39628682 |
| 13 | protein retention in ER lumen (GO:0006621) | 4.28027531 |
| 14 | proteasome assembly (GO:0043248) | 4.25569617 |
| 15 | guanosine-containing compound biosynthetic process (GO:1901070) | 4.24075422 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 4.17178037 |
| 17 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.16994174 |
| 18 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.10133400 |
| 19 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.07946836 |
| 20 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.05607606 |
| 21 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.05607606 |
| 22 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.05271818 |
| 23 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.05271818 |
| 24 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.05271818 |
| 25 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 4.04440916 |
| 26 | GTP biosynthetic process (GO:0006183) | 3.98444020 |
| 27 | negative regulation of ligase activity (GO:0051352) | 3.96522915 |
| 28 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.96522915 |
| 29 | protein neddylation (GO:0045116) | 3.94237012 |
| 30 | cytochrome complex assembly (GO:0017004) | 3.92032295 |
| 31 | protein complex biogenesis (GO:0070271) | 3.91743553 |
| 32 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.90962934 |
| 33 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.88683252 |
| 34 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.88683252 |
| 35 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.85348436 |
| 36 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.84548540 |
| 37 | GDP-mannose metabolic process (GO:0019673) | 3.80756931 |
| 38 | respiratory chain complex IV assembly (GO:0008535) | 3.78878607 |
| 39 | iron-sulfur cluster assembly (GO:0016226) | 3.78347498 |
| 40 | metallo-sulfur cluster assembly (GO:0031163) | 3.78347498 |
| 41 | respiratory electron transport chain (GO:0022904) | 3.77954388 |
| 42 | termination of RNA polymerase III transcription (GO:0006386) | 3.76646531 |
| 43 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.76646531 |
| 44 | electron transport chain (GO:0022900) | 3.74683062 |
| 45 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.70799819 |
| 46 | prostaglandin biosynthetic process (GO:0001516) | 3.70046859 |
| 47 | prostanoid biosynthetic process (GO:0046457) | 3.70046859 |
| 48 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.68856642 |
| 49 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.64235401 |
| 50 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.61875210 |
| 51 | NADH dehydrogenase complex assembly (GO:0010257) | 3.61875210 |
| 52 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.61875210 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.60839926 |
| 54 | chaperone-mediated protein transport (GO:0072321) | 3.59643776 |
| 55 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.54886665 |
| 56 | desmosome organization (GO:0002934) | 3.52667631 |
| 57 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.51288269 |
| 58 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.43856366 |
| 59 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.43215011 |
| 60 | UV protection (GO:0009650) | 3.41471391 |
| 61 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.40797228 |
| 62 | 7-methylguanosine mRNA capping (GO:0006370) | 3.40555592 |
| 63 | extracellular fibril organization (GO:0043206) | 3.38631347 |
| 64 | cotranslational protein targeting to membrane (GO:0006613) | 3.37160749 |
| 65 | viral transcription (GO:0019083) | 3.37018125 |
| 66 | UTP biosynthetic process (GO:0006228) | 3.36794837 |
| 67 | regulation of cellular amine metabolic process (GO:0033238) | 3.35204234 |
| 68 | protein targeting to ER (GO:0045047) | 3.34826750 |
| 69 | 7-methylguanosine RNA capping (GO:0009452) | 3.34562618 |
| 70 | RNA capping (GO:0036260) | 3.34562618 |
| 71 | signal peptide processing (GO:0006465) | 3.32419937 |
| 72 | positive regulation of ligase activity (GO:0051351) | 3.31709553 |
| 73 | protein localization to endoplasmic reticulum (GO:0070972) | 3.25576416 |
| 74 | positive regulation of cell cycle arrest (GO:0071158) | 3.24884817 |
| 75 | base-excision repair, AP site formation (GO:0006285) | 3.24464834 |
| 76 | regulation of mitochondrial translation (GO:0070129) | 3.23593418 |
| 77 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.23242753 |
| 78 | COPI coating of Golgi vesicle (GO:0048205) | 3.22707634 |
| 79 | Golgi transport vesicle coating (GO:0048200) | 3.22707634 |
| 80 | cellular copper ion homeostasis (GO:0006878) | 3.21463682 |
| 81 | amino sugar catabolic process (GO:0046348) | 3.18671946 |
| 82 | nuclear envelope reassembly (GO:0031468) | 3.18112734 |
| 83 | mitotic nuclear envelope reassembly (GO:0007084) | 3.18112734 |
| 84 | translational termination (GO:0006415) | 3.17338630 |
| 85 | translation (GO:0006412) | 3.17098350 |
| 86 | cell-substrate junction assembly (GO:0007044) | 3.14514462 |
| 87 | oxidative phosphorylation (GO:0006119) | 3.13639500 |
| 88 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.10191765 |
| 89 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.10148738 |
| 90 | GMP metabolic process (GO:0046037) | 3.09903234 |
| 91 | negative regulation of mitochondrion organization (GO:0010823) | 3.06659656 |
| 92 | positive regulation of actin filament depolymerization (GO:0030836) | 3.05981011 |
| 93 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.04167434 |
| 94 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.04167434 |
| 95 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.03423774 |
| 96 | cyclooxygenase pathway (GO:0019371) | 3.02520308 |
| 97 | ribosomal small subunit biogenesis (GO:0042274) | 3.01849814 |
| 98 | cullin deneddylation (GO:0010388) | 2.99748185 |
| 99 | positive regulation of TOR signaling (GO:0032008) | 2.97239729 |
| 100 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.96938526 |
| 101 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.94819561 |
| 102 | protein targeting to mitochondrion (GO:0006626) | 2.94609412 |
| 103 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.92318228 |
| 104 | protein insertion into membrane (GO:0051205) | 2.89468625 |
| 105 | establishment of protein localization to mitochondrion (GO:0072655) | 2.88697409 |
| 106 | positive regulation of pseudopodium assembly (GO:0031274) | 2.87255328 |
| 107 | translational elongation (GO:0006414) | 2.86694653 |
| 108 | ribosomal large subunit biogenesis (GO:0042273) | 2.86316442 |
| 109 | positive regulation of mitochondrial fission (GO:0090141) | 2.85406796 |
| 110 | lipoxygenase pathway (GO:0019372) | 2.84908782 |
| 111 | peptidyl-histidine modification (GO:0018202) | 2.84853724 |
| 112 | protein-cofactor linkage (GO:0018065) | 2.84289498 |
| 113 | UTP metabolic process (GO:0046051) | 2.84073568 |
| 114 | lipopolysaccharide metabolic process (GO:0008653) | 2.83543811 |
| 115 | CTP biosynthetic process (GO:0006241) | 2.82960291 |
| 116 | CTP metabolic process (GO:0046036) | 2.82960291 |
| 117 | response to misfolded protein (GO:0051788) | 2.82413384 |
| 118 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.82328422 |
| 119 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.81976535 |
| 120 | regulation of autophagic vacuole assembly (GO:2000785) | 2.81682890 |
| 121 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.79941671 |
| 122 | virion assembly (GO:0019068) | 2.78957435 |
| 123 | protein deneddylation (GO:0000338) | 2.78458116 |
| 124 | viral life cycle (GO:0019058) | 2.76803509 |
| 125 | de novo posttranslational protein folding (GO:0051084) | 2.75562238 |
| 126 | regulation of ligase activity (GO:0051340) | 2.72643183 |
| 127 | hydrogen peroxide catabolic process (GO:0042744) | 2.72427172 |
| 128 | deoxyribonucleotide catabolic process (GO:0009264) | 2.71117298 |
| 129 | barbed-end actin filament capping (GO:0051016) | 2.70421937 |
| 130 | hydrogen ion transmembrane transport (GO:1902600) | 2.70228216 |
| 131 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.69470785 |
| 132 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.68067830 |
| 133 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.66603242 |
| 134 | cellular protein complex disassembly (GO:0043624) | 2.66581587 |
| 135 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.66044929 |
| 136 | mannosylation (GO:0097502) | 2.65979819 |
| 137 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.65372226 |
| 138 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.63209211 |
| 139 | fibril organization (GO:0097435) | 2.60733544 |
| 140 | copper ion homeostasis (GO:0055070) | 2.59005017 |
| 141 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.58634244 |
| 142 | protein localization to endosome (GO:0036010) | 2.57437086 |
| 143 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.57345765 |
| 144 | proline biosynthetic process (GO:0006561) | 2.57190590 |
| 145 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.56482188 |
| 146 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.56073364 |
| 147 | heme biosynthetic process (GO:0006783) | 2.55184587 |
| 148 | synaptic vesicle exocytosis (GO:0016079) | 2.54993813 |
| 149 | regulation of vacuole organization (GO:0044088) | 2.53577742 |
| 150 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.49896024 |
| 151 | viral protein processing (GO:0019082) | 2.49319923 |
| 152 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.48199737 |
| 153 | regulation of pseudopodium assembly (GO:0031272) | 2.46051285 |
| 154 | regulation of protein targeting to membrane (GO:0090313) | 2.45263955 |
| 155 | prostanoid metabolic process (GO:0006692) | 2.42229809 |
| 156 | prostaglandin metabolic process (GO:0006693) | 2.42229809 |
| 157 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.41904147 |
| 158 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.41848008 |
| 159 | regulation of metalloenzyme activity (GO:0048552) | 2.38699447 |
| 160 | deoxyribose phosphate catabolic process (GO:0046386) | 2.37255942 |
| 161 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.35357268 |
| 162 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.33360582 |
| 163 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.33360582 |
| 164 | L-serine transport (GO:0015825) | 2.32355847 |
| 165 | pyrimidine-containing compound salvage (GO:0008655) | 2.30046633 |
| 166 | pyrimidine nucleoside salvage (GO:0043097) | 2.30046633 |
| 167 | positive regulation of protein targeting to membrane (GO:0090314) | 2.29575650 |
| 168 | protein localization to mitochondrion (GO:0070585) | 2.29519149 |
| 169 | neuronal ion channel clustering (GO:0045161) | 2.27132110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.60477340 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.28048171 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.08466215 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.90398522 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.87665133 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.59994386 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.51482081 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.36619006 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.31754378 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.27995964 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.23624171 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.94588986 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.78363605 |
| 14 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.71187516 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.65004907 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.50148451 |
| 17 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.49385569 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.48527876 |
| 19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.43976923 |
| 20 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.40562267 |
| 21 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.38617320 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.38590651 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.38427701 |
| 24 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.31520213 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.24891786 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.23442033 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11915991 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08997404 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.07211335 |
| 30 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.99271449 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.98014959 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.97607584 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.94765325 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.90781037 |
| 35 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.89815705 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87709959 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.85357445 |
| 38 | P68_20966046_ChIP-Seq_HELA_Human | 1.83347024 |
| 39 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.75856281 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.75566284 |
| 41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.74469062 |
| 42 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.74347641 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71549062 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.71036708 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68333866 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65332594 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.59672586 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59161691 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.58301853 |
| 50 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.57624727 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57590355 |
| 52 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53333518 |
| 53 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.52397435 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.52222819 |
| 55 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.51917707 |
| 56 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.50381947 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49680384 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49025641 |
| 59 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.48614360 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.43446499 |
| 61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.43382099 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42944729 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41564146 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41047459 |
| 65 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40116986 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39394393 |
| 67 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.39242851 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38787368 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38383292 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37393055 |
| 71 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.36976995 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35499470 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34061351 |
| 74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.33503264 |
| 75 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32415996 |
| 76 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31991710 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31762161 |
| 78 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29414794 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29025643 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28835028 |
| 81 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28235281 |
| 82 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.27594385 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27296145 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26852109 |
| 85 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.26762879 |
| 86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26751586 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26619143 |
| 88 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.25249389 |
| 89 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.24305614 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22193586 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21841344 |
| 92 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.21369315 |
| 93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21368326 |
| 94 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20766055 |
| 95 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.20452279 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.19685617 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17238238 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.16120188 |
| 99 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15183204 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15075340 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14816963 |
| 102 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.14397767 |
| 103 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14053075 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13501126 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12132146 |
| 106 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10294974 |
| 107 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.10230925 |
| 108 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09366358 |
| 109 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08504071 |
| 110 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07767436 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07435115 |
| 112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06687323 |
| 113 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06075816 |
| 114 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05764204 |
| 115 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05289370 |
| 116 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05207987 |
| 117 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04218335 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04198708 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03000869 |
| 120 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02543415 |
| 121 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02315867 |
| 122 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01991322 |
| 123 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.01385123 |
| 124 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01311578 |
| 125 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01204413 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00964418 |
| 127 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00924816 |
| 128 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00274566 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99682591 |
| 130 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98870444 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98645874 |
| 132 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98414898 |
| 133 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98148691 |
| 134 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97781966 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96907603 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96791481 |
| 137 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96628681 |
| 138 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95570974 |
| 139 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94916291 |
| 140 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94566683 |
| 141 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94120925 |
| 142 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93983315 |
| 143 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93115036 |
| 144 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91987370 |
| 145 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.91756181 |
| 146 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91232611 |
| 147 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90096078 |
| 148 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89334749 |
| 149 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.88534332 |
| 150 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88519286 |
| 151 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88082275 |
| 152 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87364357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000579_abnormal_nail_morphology | 4.31489358 |
| 2 | MP0008260_abnormal_autophagy | 3.24592172 |
| 3 | MP0001542_abnormal_bone_strength | 3.05662661 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.03046135 |
| 5 | MP0003186_abnormal_redox_activity | 3.00066681 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.86279043 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.83841253 |
| 8 | MP0003329_amyloid_beta_deposits | 2.52339293 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.51637588 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.50619578 |
| 11 | MP0001849_ear_inflammation | 2.49882261 |
| 12 | MP0004272_abnormal_basement_membrane | 2.48535140 |
| 13 | MP0009785_altered_susceptibility_to | 2.39688759 |
| 14 | MP0002234_abnormal_pharynx_morphology | 2.38534672 |
| 15 | MP0003693_abnormal_embryo_hatching | 2.22460026 |
| 16 | MP0003724_increased_susceptibility_to | 2.17722161 |
| 17 | MP0000372_irregular_coat_pigmentation | 2.13978003 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 2.11711682 |
| 19 | MP0000467_abnormal_esophagus_morphology | 2.09972449 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.09010718 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.03174040 |
| 22 | MP0009379_abnormal_foot_pigmentation | 2.02339767 |
| 23 | MP0005451_abnormal_body_composition | 2.02292778 |
| 24 | MP0004858_abnormal_nervous_system | 2.01348092 |
| 25 | MP0009840_abnormal_foam_cell | 2.00806322 |
| 26 | MP0000762_abnormal_tongue_morphology | 1.96343724 |
| 27 | MP0009053_abnormal_anal_canal | 1.94794285 |
| 28 | MP0002060_abnormal_skin_morphology | 1.93483425 |
| 29 | MP0003436_decreased_susceptibility_to | 1.90928865 |
| 30 | MP0002736_abnormal_nociception_after | 1.90377599 |
| 31 | MP0002653_abnormal_ependyma_morphology | 1.89347765 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.80370246 |
| 33 | MP0005083_abnormal_biliary_tract | 1.80368695 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.80229299 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.76960043 |
| 36 | MP0002822_catalepsy | 1.74693311 |
| 37 | MP0003075_altered_response_to | 1.72449662 |
| 38 | MP0002132_abnormal_respiratory_system | 1.71772463 |
| 39 | MP0005025_abnormal_response_to | 1.70125001 |
| 40 | MP0000678_abnormal_parathyroid_gland | 1.68868848 |
| 41 | MP0002419_abnormal_innate_immunity | 1.68788147 |
| 42 | MP0005360_urolithiasis | 1.68301720 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.67382444 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.66628098 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.66295713 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.66146856 |
| 47 | MP0005501_abnormal_skin_physiology | 1.65994735 |
| 48 | MP0001984_abnormal_olfaction | 1.65199994 |
| 49 | MP0006082_CNS_inflammation | 1.64392757 |
| 50 | MP0001905_abnormal_dopamine_level | 1.61925395 |
| 51 | MP0004883_abnormal_blood_vessel | 1.61602380 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.61498374 |
| 53 | MP0005670_abnormal_white_adipose | 1.60183395 |
| 54 | MP0001764_abnormal_homeostasis | 1.60086873 |
| 55 | MP0005623_abnormal_meninges_morphology | 1.60041169 |
| 56 | MP0009697_abnormal_copulation | 1.58993605 |
| 57 | MP0000537_abnormal_urethra_morphology | 1.58039549 |
| 58 | MP0010771_integument_phenotype | 1.55131687 |
| 59 | MP0000343_altered_response_to | 1.52332986 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.51963012 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.48207293 |
| 62 | MP0000751_myopathy | 1.48084884 |
| 63 | MP0006054_spinal_hemorrhage | 1.47041240 |
| 64 | MP0003718_maternal_effect | 1.47006574 |
| 65 | MP0000750_abnormal_muscle_regeneration | 1.46219980 |
| 66 | MP0010030_abnormal_orbit_morphology | 1.46031151 |
| 67 | MP0005165_increased_susceptibility_to | 1.46002424 |
| 68 | MP0010386_abnormal_urinary_bladder | 1.45896883 |
| 69 | MP0001216_abnormal_epidermal_layer | 1.44134699 |
| 70 | MP0001853_heart_inflammation | 1.43975110 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 1.42814675 |
| 72 | MP0000685_abnormal_immune_system | 1.39755025 |
| 73 | MP0005164_abnormal_response_to | 1.38229221 |
| 74 | MP0001968_abnormal_touch/_nociception | 1.34350647 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.34158430 |
| 76 | MP0005671_abnormal_response_to | 1.32757523 |
| 77 | MP0002163_abnormal_gland_morphology | 1.32591220 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32489530 |
| 79 | MP0005409_darkened_coat_color | 1.32266944 |
| 80 | MP0006276_abnormal_autonomic_nervous | 1.30846784 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.30743982 |
| 82 | MP0008469_abnormal_protein_level | 1.28639486 |
| 83 | MP0002735_abnormal_chemical_nociception | 1.27862030 |
| 84 | MP0001756_abnormal_urination | 1.27427288 |
| 85 | * MP0002160_abnormal_reproductive_system | 1.27409356 |
| 86 | MP0005394_taste/olfaction_phenotype | 1.25170394 |
| 87 | MP0005499_abnormal_olfactory_system | 1.25170394 |
| 88 | MP0003136_yellow_coat_color | 1.24700229 |
| 89 | MP0000358_abnormal_cell_content/ | 1.23613433 |
| 90 | MP0000858_altered_metastatic_potential | 1.20403819 |
| 91 | MP0003878_abnormal_ear_physiology | 1.20245180 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 1.20245180 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 1.19029457 |
| 94 | MP0000490_abnormal_crypts_of | 1.16924671 |
| 95 | MP0005408_hypopigmentation | 1.16662463 |
| 96 | MP0003879_abnormal_hair_cell | 1.16243216 |
| 97 | * MP0002452_abnormal_antigen_presenting | 1.15691880 |
| 98 | MP0001845_abnormal_inflammatory_respons | 1.14047836 |
| 99 | MP0005330_cardiomyopathy | 1.11294726 |
| 100 | MP0005423_abnormal_somatic_nervous | 1.10350139 |
| 101 | MP0002723_abnormal_immune_serum | 1.10293426 |
| 102 | MP0008789_abnormal_olfactory_epithelium | 1.09652712 |
| 103 | MP0003123_paternal_imprinting | 1.09165069 |
| 104 | * MP0001819_abnormal_immune_cell | 1.06969115 |
| 105 | MP0005636_abnormal_mineral_homeostasis | 1.06730223 |
| 106 | MP0000604_amyloidosis | 1.06340081 |
| 107 | MP0002796_impaired_skin_barrier | 1.06095477 |
| 108 | MP0005503_abnormal_tendon_morphology | 1.05560061 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 1.05037107 |
| 110 | MP0008874_decreased_physiological_sensi | 1.04507289 |
| 111 | MP0005171_absent_coat_pigmentation | 1.04013373 |
| 112 | * MP0002420_abnormal_adaptive_immunity | 1.03710758 |
| 113 | MP0003011_delayed_dark_adaptation | 1.03082719 |
| 114 | MP0005023_abnormal_wound_healing | 1.02653425 |
| 115 | MP0003866_abnormal_defecation | 1.02580064 |
| 116 | MP0005275_abnormal_skin_tensile | 1.01764042 |
| 117 | MP0005410_abnormal_fertilization | 1.01138471 |
| 118 | MP0002638_abnormal_pupillary_reflex | 0.98496738 |
| 119 | MP0009764_decreased_sensitivity_to | 0.97918156 |
| 120 | MP0004147_increased_porphyrin_level | 0.97390908 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.97342154 |
| 122 | MP0002751_abnormal_autonomic_nervous | 0.96572339 |
| 123 | MP0005332_abnormal_amino_acid | 0.95373101 |
| 124 | MP0002295_abnormal_pulmonary_circulatio | 0.95034378 |
| 125 | MP0002909_abnormal_adrenal_gland | 0.91429310 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.90717586 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.90610193 |
| 128 | MP0002405_respiratory_system_inflammati | 0.90456443 |
| 129 | MP0003880_abnormal_central_pattern | 0.90337177 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.90107357 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.89697755 |
| 132 | MP0001958_emphysema | 0.88978843 |
| 133 | MP0002098_abnormal_vibrissa_morphology | 0.88932651 |
| 134 | MP0004510_myositis | 0.88702399 |
| 135 | MP0000538_abnormal_urinary_bladder | 0.88453602 |
| 136 | MP0002733_abnormal_thermal_nociception | 0.87902144 |
| 137 | MP0003635_abnormal_synaptic_transmissio | 0.87269052 |
| 138 | MP0000013_abnormal_adipose_tissue | 0.85134495 |
| 139 | MP0005390_skeleton_phenotype | 0.83871321 |
| 140 | MP0003279_aneurysm | 0.82954926 |
| 141 | MP0010368_abnormal_lymphatic_system | 0.82446900 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.81157190 |
| 143 | MP0001970_abnormal_pain_threshold | 0.81134678 |
| 144 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80737219 |
| 145 | MP0000003_abnormal_adipose_tissue | 0.80672264 |
| 146 | MP0002332_abnormal_exercise_endurance | 0.76284071 |
| 147 | MP0001529_abnormal_vocalization | 0.74844323 |
| 148 | MP0004270_analgesia | 0.74720504 |
| 149 | MP0004019_abnormal_vitamin_homeostasis | 0.74714414 |
| 150 | MP0003315_abnormal_perineum_morphology | 0.73779780 |
| 151 | MP0009780_abnormal_chondrocyte_physiolo | 0.73749863 |
| 152 | MP0001790_abnormal_immune_system | 0.73038920 |
| 153 | MP0005387_immune_system_phenotype | 0.73038920 |
| 154 | MP0002277_abnormal_respiratory_mucosa | 0.72325122 |
| 155 | MP0009278_abnormal_bone_marrow | 0.72258891 |
| 156 | * MP0003634_abnormal_glial_cell | 0.71826543 |
| 157 | MP0009931_abnormal_skin_appearance | 0.71779892 |
| 158 | MP0005319_abnormal_enzyme/_coenzyme | 0.71368621 |
| 159 | MP0003195_calcinosis | 0.71221916 |
| 160 | MP0002998_abnormal_bone_remodeling | 0.69689459 |
| 161 | MP0002734_abnormal_mechanical_nocicepti | 0.68563950 |
| 162 | MP0002572_abnormal_emotion/affect_behav | 0.66201500 |
| 163 | MP0005193_abnormal_anterior_eye | 0.66081652 |
| 164 | MP0002064_seizures | 0.64498482 |
| 165 | MP0002272_abnormal_nervous_system | 0.63052672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fragile nails (HP:0001808) | 5.95311332 |
| 2 | Onycholysis (HP:0001806) | 5.86508864 |
| 3 | Atrophic scars (HP:0001075) | 5.50853152 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.80553255 |
| 5 | Milia (HP:0001056) | 4.72192976 |
| 6 | Mitochondrial inheritance (HP:0001427) | 4.70542801 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.62748804 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.27714116 |
| 9 | Hepatic necrosis (HP:0002605) | 4.23553597 |
| 10 | Increased CSF lactate (HP:0002490) | 4.03784375 |
| 11 | Acute encephalopathy (HP:0006846) | 3.80577812 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.77731555 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.76907336 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 3.73395585 |
| 15 | Plantar hyperkeratosis (HP:0007556) | 3.64842071 |
| 16 | Nail dystrophy (HP:0008404) | 3.61474027 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.51775988 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.43837722 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.34048358 |
| 20 | Exertional dyspnea (HP:0002875) | 3.30170206 |
| 21 | Petechiae (HP:0000967) | 3.27676791 |
| 22 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.26532187 |
| 23 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.17366690 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.17032050 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.17032050 |
| 26 | Myokymia (HP:0002411) | 3.16477132 |
| 27 | Alopecia of scalp (HP:0002293) | 3.05390320 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.96465556 |
| 29 | Type I transferrin isoform profile (HP:0003642) | 2.91538338 |
| 30 | Respiratory failure (HP:0002878) | 2.88203597 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.87657849 |
| 32 | Abnormal number of erythroid precursors (HP:0012131) | 2.87476729 |
| 33 | Hypothermia (HP:0002045) | 2.85888807 |
| 34 | Increased serum lactate (HP:0002151) | 2.85832323 |
| 35 | Poor head control (HP:0002421) | 2.79222217 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 2.78952322 |
| 37 | Exercise intolerance (HP:0003546) | 2.76447872 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 2.76158355 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.76022971 |
| 40 | Lactic acidosis (HP:0003128) | 2.75866902 |
| 41 | Distal lower limb muscle weakness (HP:0009053) | 2.75341097 |
| 42 | Testicular atrophy (HP:0000029) | 2.69930169 |
| 43 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.64420311 |
| 44 | Hand muscle atrophy (HP:0009130) | 2.62229359 |
| 45 | Abnormality of nail color (HP:0100643) | 2.61806275 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.60402926 |
| 47 | Pili torti (HP:0003777) | 2.59881826 |
| 48 | Abnormal blistering of the skin (HP:0008066) | 2.56069313 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.53215355 |
| 50 | Achilles tendon contracture (HP:0001771) | 2.52688791 |
| 51 | Purpura (HP:0000979) | 2.52581614 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 2.52524048 |
| 53 | Upper limb amyotrophy (HP:0009129) | 2.52524048 |
| 54 | Sparse eyelashes (HP:0000653) | 2.51550276 |
| 55 | Increased muscle lipid content (HP:0009058) | 2.50863943 |
| 56 | Cerebral edema (HP:0002181) | 2.49626551 |
| 57 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.44683856 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.41854621 |
| 59 | Death in infancy (HP:0001522) | 2.39526616 |
| 60 | Eczematoid dermatitis (HP:0000976) | 2.38322297 |
| 61 | Abnormality of renal resorption (HP:0011038) | 2.34951999 |
| 62 | Aplastic anemia (HP:0001915) | 2.34806464 |
| 63 | Hydroureter (HP:0000072) | 2.32857970 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.31874192 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.31765971 |
| 66 | Cholecystitis (HP:0001082) | 2.31765971 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 2.30323062 |
| 68 | Thick nail (HP:0001805) | 2.29779963 |
| 69 | Growth hormone excess (HP:0000845) | 2.29576207 |
| 70 | Fragile skin (HP:0001030) | 2.28845167 |
| 71 | Abnormality of urine glucose concentration (HP:0011016) | 2.27142071 |
| 72 | Glycosuria (HP:0003076) | 2.27142071 |
| 73 | Reduced antithrombin III activity (HP:0001976) | 2.25951895 |
| 74 | Respiratory difficulties (HP:0002880) | 2.21390412 |
| 75 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.20836483 |
| 76 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.20836483 |
| 77 | Abnormal protein glycosylation (HP:0012346) | 2.20836483 |
| 78 | Abnormal glycosylation (HP:0012345) | 2.20836483 |
| 79 | Optic disc pallor (HP:0000543) | 2.19989925 |
| 80 | Abnormal hair laboratory examination (HP:0003328) | 2.19810700 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.19301734 |
| 82 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15774713 |
| 83 | Cervical subluxation (HP:0003308) | 2.13099047 |
| 84 | Short nail (HP:0001799) | 2.11667375 |
| 85 | Hypokinesia (HP:0002375) | 2.09872684 |
| 86 | CNS demyelination (HP:0007305) | 2.09801908 |
| 87 | Leukodystrophy (HP:0002415) | 2.09763952 |
| 88 | Neoplasm of head and neck (HP:0012288) | 2.09468452 |
| 89 | Esophageal neoplasm (HP:0100751) | 2.09468452 |
| 90 | Ridged nail (HP:0001807) | 2.08851082 |
| 91 | Microretrognathia (HP:0000308) | 2.07972523 |
| 92 | Limb dystonia (HP:0002451) | 2.07458797 |
| 93 | Macrocytic anemia (HP:0001972) | 2.06183164 |
| 94 | Cerebral palsy (HP:0100021) | 2.05769110 |
| 95 | Premature rupture of membranes (HP:0001788) | 2.03370521 |
| 96 | Spastic paraparesis (HP:0002313) | 2.03002137 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 2.02826639 |
| 98 | Abnormality of the umbilical cord (HP:0010881) | 2.01660078 |
| 99 | Delusions (HP:0000746) | 2.01488084 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 2.01213677 |
| 101 | Multiple enchondromatosis (HP:0005701) | 1.99196318 |
| 102 | Tongue fasciculations (HP:0001308) | 1.98463147 |
| 103 | Erythema (HP:0010783) | 1.97603320 |
| 104 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.96764378 |
| 105 | Systemic lupus erythematosus (HP:0002725) | 1.96446964 |
| 106 | Conjunctival hamartoma (HP:0100780) | 1.96172340 |
| 107 | Opisthotonus (HP:0002179) | 1.95902085 |
| 108 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.95417353 |
| 109 | Flattened epiphyses (HP:0003071) | 1.94285554 |
| 110 | Rough bone trabeculation (HP:0100670) | 1.93940645 |
| 111 | Hypoplasia of dental enamel (HP:0006297) | 1.93688288 |
| 112 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.92773727 |
| 113 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92210742 |
| 114 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92210742 |
| 115 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92210742 |
| 116 | Abnormality of glycolysis (HP:0004366) | 1.91702217 |
| 117 | Increased serum pyruvate (HP:0003542) | 1.91702217 |
| 118 | Reticulocytopenia (HP:0001896) | 1.91508359 |
| 119 | Renal tubular dysfunction (HP:0000124) | 1.91057722 |
| 120 | Amyloidosis (HP:0011034) | 1.89970016 |
| 121 | Muscle fibrillation (HP:0010546) | 1.89606725 |
| 122 | Ragged-red muscle fibers (HP:0003200) | 1.88439390 |
| 123 | Beaking of vertebral bodies (HP:0004568) | 1.88205760 |
| 124 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.87796547 |
| 125 | Neonatal onset (HP:0003623) | 1.87615622 |
| 126 | Acanthosis nigricans (HP:0000956) | 1.87370289 |
| 127 | Prolonged neonatal jaundice (HP:0006579) | 1.86147135 |
| 128 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85727585 |
| 129 | Epiphyseal stippling (HP:0010655) | 1.85445817 |
| 130 | Emotional lability (HP:0000712) | 1.84467382 |
| 131 | Pheochromocytoma (HP:0002666) | 1.84359522 |
| 132 | Hepatosplenomegaly (HP:0001433) | 1.83812652 |
| 133 | Increased IgM level (HP:0003496) | 1.82876571 |
| 134 | Selective tooth agenesis (HP:0001592) | 1.81772853 |
| 135 | Hyperphosphaturia (HP:0003109) | 1.81473164 |
| 136 | J-shaped sella turcica (HP:0002680) | 1.80180695 |
| 137 | Difficulty climbing stairs (HP:0003551) | 1.79943970 |
| 138 | Joint stiffness (HP:0001387) | 1.79608003 |
| 139 | Axonal loss (HP:0003447) | 1.79332438 |
| 140 | Hyperparathyroidism (HP:0000843) | 1.78915915 |
| 141 | Patent foramen ovale (HP:0001655) | 1.77625997 |
| 142 | Cerebral hypomyelination (HP:0006808) | 1.76300958 |
| 143 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.76170034 |
| 144 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.76170034 |
| 145 | Single umbilical artery (HP:0001195) | 1.76170034 |
| 146 | Progressive neurologic deterioration (HP:0002344) | 1.75781205 |
| 147 | Polyphagia (HP:0002591) | 1.74865641 |
| 148 | Orchitis (HP:0100796) | 1.74420682 |
| 149 | Poor suck (HP:0002033) | 1.74319336 |
| 150 | Visual hallucinations (HP:0002367) | 1.73771928 |
| 151 | Methylmalonic aciduria (HP:0012120) | 1.73731948 |
| 152 | Biconcave vertebral bodies (HP:0004586) | 1.73314607 |
| 153 | Myositis (HP:0100614) | 1.72874801 |
| 154 | Pterygium (HP:0001059) | 1.71514691 |
| 155 | Generalized aminoaciduria (HP:0002909) | 1.70940928 |
| 156 | Abnormality of carpal bone ossification (HP:0006257) | 1.70618566 |
| 157 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.66678244 |
| 158 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.65775348 |
| 159 | Fasciculations (HP:0002380) | 1.64559858 |
| 160 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64050343 |
| 161 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64050343 |
| 162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64050343 |
| 163 | Back pain (HP:0003418) | 1.62732040 |
| 164 | Hyperthyroidism (HP:0000836) | 1.62356319 |
| 165 | Short femoral neck (HP:0100864) | 1.62200243 |
| 166 | Hypodontia (HP:0000668) | 1.61207774 |
| 167 | Hyperhidrosis (HP:0000975) | 1.60699626 |
| 168 | Abnormal trabecular bone morphology (HP:0100671) | 1.60614253 |
| 169 | Insomnia (HP:0100785) | 1.60455984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.80596853 |
| 2 | STK16 | 4.40710736 |
| 3 | VRK2 | 3.13596474 |
| 4 | BUB1 | 2.84083410 |
| 5 | TESK1 | 2.82163053 |
| 6 | LIMK1 | 2.67807537 |
| 7 | MAP3K12 | 2.59174462 |
| 8 | EPHA2 | 2.55033158 |
| 9 | * PIM2 | 2.47167792 |
| 10 | EPHB2 | 2.37134688 |
| 11 | MAP3K11 | 2.09414874 |
| 12 | MYLK | 2.04068509 |
| 13 | EIF2AK1 | 1.90161463 |
| 14 | TBK1 | 1.87269123 |
| 15 | LMTK2 | 1.86597791 |
| 16 | CAMKK2 | 1.79584659 |
| 17 | GRK5 | 1.78575942 |
| 18 | TESK2 | 1.76987013 |
| 19 | BLK | 1.68303435 |
| 20 | SIK1 | 1.67571466 |
| 21 | MST4 | 1.60633371 |
| 22 | STK24 | 1.59633073 |
| 23 | NME1 | 1.58906716 |
| 24 | TAOK1 | 1.53167974 |
| 25 | IRAK3 | 1.48520963 |
| 26 | TRIB3 | 1.45622502 |
| 27 | IRAK4 | 1.44839168 |
| 28 | EIF2AK3 | 1.44325963 |
| 29 | AKT3 | 1.42703423 |
| 30 | ABL2 | 1.41983416 |
| 31 | ILK | 1.40385831 |
| 32 | NTRK1 | 1.39747717 |
| 33 | BMPR1B | 1.37764001 |
| 34 | MST1R | 1.31934735 |
| 35 | SMG1 | 1.27772868 |
| 36 | MAP2K2 | 1.26938862 |
| 37 | CASK | 1.23724382 |
| 38 | MAP3K3 | 1.20454364 |
| 39 | VRK1 | 1.19827601 |
| 40 | WEE1 | 1.19291091 |
| 41 | PAK4 | 1.17884962 |
| 42 | TSSK6 | 1.16494661 |
| 43 | MAP3K14 | 1.14505816 |
| 44 | PAK6 | 1.13435114 |
| 45 | BRSK2 | 1.12919940 |
| 46 | TYK2 | 1.11269987 |
| 47 | PTK2 | 1.11120157 |
| 48 | ZAK | 1.09014509 |
| 49 | TLK1 | 1.07694713 |
| 50 | BMPR2 | 1.07649333 |
| 51 | PRKD2 | 1.05010318 |
| 52 | DYRK2 | 1.04524431 |
| 53 | ADRBK2 | 1.03811805 |
| 54 | PHKG1 | 1.03523556 |
| 55 | PHKG2 | 1.03523556 |
| 56 | SIK3 | 1.03428991 |
| 57 | NEK1 | 1.02492068 |
| 58 | CCNB1 | 1.00899424 |
| 59 | MAPKAPK3 | 1.00837755 |
| 60 | MINK1 | 0.99464579 |
| 61 | PRKD3 | 0.97764292 |
| 62 | AURKA | 0.96670319 |
| 63 | TEC | 0.96397399 |
| 64 | ERN1 | 0.95421489 |
| 65 | IKBKB | 0.93226364 |
| 66 | DAPK3 | 0.92837359 |
| 67 | CSNK1A1L | 0.92287021 |
| 68 | MATK | 0.91739899 |
| 69 | MAP2K3 | 0.91218567 |
| 70 | PLK4 | 0.90998871 |
| 71 | MAP4K2 | 0.90542038 |
| 72 | * PAK1 | 0.88017207 |
| 73 | CSNK1G2 | 0.87653686 |
| 74 | KDR | 0.87091651 |
| 75 | CDK8 | 0.85686345 |
| 76 | EPHA4 | 0.84236721 |
| 77 | KIT | 0.83297742 |
| 78 | TAOK2 | 0.83117544 |
| 79 | BCKDK | 0.83051271 |
| 80 | GRK7 | 0.82633046 |
| 81 | MUSK | 0.81726392 |
| 82 | DAPK1 | 0.79953064 |
| 83 | ERBB3 | 0.79531518 |
| 84 | LRRK2 | 0.78930442 |
| 85 | GRK6 | 0.78671304 |
| 86 | MET | 0.78443545 |
| 87 | SYK | 0.77635478 |
| 88 | BRSK1 | 0.76364005 |
| 89 | * PRKCI | 0.76229560 |
| 90 | * CAMK2G | 0.75887681 |
| 91 | CDK14 | 0.75182060 |
| 92 | MAPKAPK2 | 0.73392094 |
| 93 | * RPS6KA6 | 0.72959409 |
| 94 | ZAP70 | 0.72456418 |
| 95 | PLK3 | 0.72130281 |
| 96 | EIF2AK2 | 0.70787373 |
| 97 | BMX | 0.67915279 |
| 98 | DYRK3 | 0.67116705 |
| 99 | NEK9 | 0.67115789 |
| 100 | MAPKAPK5 | 0.66977655 |
| 101 | PINK1 | 0.66321306 |
| 102 | RIPK1 | 0.66318437 |
| 103 | BCR | 0.66255865 |
| 104 | MARK1 | 0.65498534 |
| 105 | * RPS6KL1 | 0.64841331 |
| 106 | * RPS6KC1 | 0.64841331 |
| 107 | BTK | 0.64732604 |
| 108 | MAP4K1 | 0.64725569 |
| 109 | IKBKE | 0.64583123 |
| 110 | CDK11A | 0.64193794 |
| 111 | SCYL2 | 0.63383919 |
| 112 | CDK15 | 0.62267211 |
| 113 | PLK2 | 0.62015639 |
| 114 | CDK18 | 0.60553096 |
| 115 | RPS6KA4 | 0.57834512 |
| 116 | CSNK1G3 | 0.56448948 |
| 117 | CAMK2B | 0.56178172 |
| 118 | CSNK1G1 | 0.56082214 |
| 119 | ROCK2 | 0.55121126 |
| 120 | TNK2 | 0.55058814 |
| 121 | ICK | 0.54284669 |
| 122 | MOS | 0.53611851 |
| 123 | DAPK2 | 0.51826826 |
| 124 | PRKCD | 0.51367108 |
| 125 | MAP2K1 | 0.50835553 |
| 126 | RIPK4 | 0.48329038 |
| 127 | CAMK2D | 0.48318784 |
| 128 | PRKG2 | 0.47362976 |
| 129 | MAPK4 | 0.46242083 |
| 130 | * CSNK2A1 | 0.45866294 |
| 131 | MAP2K7 | 0.45757911 |
| 132 | PDK2 | 0.44727727 |
| 133 | FER | 0.44709618 |
| 134 | PKN1 | 0.42949995 |
| 135 | CDK19 | 0.42909022 |
| 136 | AKT2 | 0.42882473 |
| 137 | LYN | 0.42812350 |
| 138 | ADRBK1 | 0.42741066 |
| 139 | ACVR1B | 0.41358728 |
| 140 | PTK2B | 0.41284115 |
| 141 | * BRAF | 0.40281489 |
| 142 | MARK2 | 0.40140827 |
| 143 | * PRKD1 | 0.39667523 |
| 144 | ROCK1 | 0.39107017 |
| 145 | PBK | 0.37500406 |
| 146 | STK38 | 0.34802540 |
| 147 | PLK1 | 0.34785717 |
| 148 | FLT3 | 0.33887660 |
| 149 | TGFBR1 | 0.33373829 |
| 150 | PKN2 | 0.32682783 |
| 151 | CDK5 | 0.31816854 |
| 152 | IRAK2 | 0.31311462 |
| 153 | PDPK1 | 0.30516826 |
| 154 | PIK3CG | 0.29695208 |
| 155 | CAMKK1 | 0.29163875 |
| 156 | DDR2 | 0.28346484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.46524054 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.15568394 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 4.06443686 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.62662166 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.25167335 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.92222528 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.68981395 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.33847750 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.26217966 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.25573781 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.24369921 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09964383 |
| 13 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.08175522 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.99246224 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.75492827 |
| 16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.73630050 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.67303009 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.65880658 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.50904455 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.49785555 |
| 21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.43473104 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.41972124 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41805064 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38968652 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37522651 |
| 26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37008955 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.36297123 |
| 28 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.32926173 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29517547 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28843439 |
| 31 | Purine metabolism_Homo sapiens_hsa00230 | 1.28032066 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.25976474 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25802399 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.24070141 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23101545 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19900748 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18419095 |
| 38 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.13739849 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11899551 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11751823 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10240530 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.05109183 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03175043 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02312489 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.99517825 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95098509 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91111910 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89433709 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88820844 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.86364579 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 0.85760177 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85260416 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.84188908 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.82891605 |
| 55 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82879503 |
| 56 | Spliceosome_Homo sapiens_hsa03040 | 0.81002050 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80279000 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.80155320 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.77836484 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 0.77781198 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.76724143 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.76523555 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74632691 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74343151 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74009655 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72887738 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71788351 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70866304 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70842464 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70057917 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69425441 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67487131 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67129062 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.65859303 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.64350977 |
| 76 | Salivary secretion_Homo sapiens_hsa04970 | 0.61942517 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60419539 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58925140 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58871671 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58470033 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.57986093 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57424360 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56771484 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54831749 |
| 85 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53574848 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51981198 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.49370724 |
| 88 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49072429 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49002495 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48588824 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.48122081 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47161763 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46735273 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46242325 |
| 95 | * Tuberculosis_Homo sapiens_hsa05152 | 0.45756109 |
| 96 | * Apoptosis_Homo sapiens_hsa04210 | 0.45308049 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43655284 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.43605424 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42520148 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42353075 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42082147 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41968927 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41642328 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.41445042 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40256736 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39303053 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38020693 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.37948458 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.37429852 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36345499 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35803287 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35746156 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33275980 |
| 114 | RNA transport_Homo sapiens_hsa03013 | 0.29794031 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.29770431 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29205118 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29114141 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27647222 |
| 119 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27334618 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27311228 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27097439 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27012451 |
| 123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26811830 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.26059823 |
| 125 | * Focal adhesion_Homo sapiens_hsa04510 | 0.24930739 |
| 126 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.24626138 |
| 127 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24436398 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24111733 |
| 129 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.23807648 |
| 130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23310005 |
| 131 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.22586929 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22531364 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20271355 |
| 134 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.18933034 |
| 135 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18508623 |
| 136 | GABAergic synapse_Homo sapiens_hsa04727 | 0.18280427 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.16197271 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.15418730 |

